Phoenix doctor wins Potamkin PrizePosted: January 24, 2013 | |
Mazel tov to Dr. Eric M. Reiman of the Banner Alzheimer’s Institute here in Phoenix for being one of three researchers to receive the 2013 Potamkin Prize for Research in Pick’s, Alzheimer’s and Related Diseases from the American Academy of Neurology. (Watch Jewish News for a deeper article about the award and his work in an upcoming issue.)
He will share the $100,000 award, along with Dr. William J. Jagust of the University of California, Berkeley and Dr. Michael W. Weiner of the San Francisco VA Medical Center at the academy’s 65th annual meeting, scheduled for March 16-23 in San Diego.
The academy announced that Reiman was being recognized for his efforts to characterize some of the earliest brain changes associated with the predisposition to Alzheimer’s disease, accelerate the evaluation of promising prevention therapies and help establish the Alzheimer’s Prevention Initiative .
“I am grateful for the opportunity to help launch a new era in Alzheimer’s prevention research and seek treatments to end this devastating disease without losing another generation,” Reiman was quoted as saying in the academy’s announcement. “It has been a privilege to work with my research colleagues, collaborators and other outstanding individuals in the pursuit of our shared goals.”
The Potamkin Prize is named after the Potamkin family of Colorado, Philadelphia and Miami, which has provided more than $2.5 million to fund the prize. The prize is meant to help attract the best medical minds and most dedicated scientists in the world to the field of dementia research. The Potamkin family has been the Academy’s single largest individual donor since 1988, providing more than $2.5 million to fund the Potamkin Prize. Learn more about Pick’s, Alzheimer’s disease and related diseases at the American Academy of Neurology’s site.
The academy is an association of more than 25,000 neurologists and neuroscience professionals, those with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson’s disease and epilepsy.